April 30, 2010
Molecular Imaging Can Identify A Potentially Deadly Blood Vessel Condition
Early diagnosis and treatment essential for patients with aortic dissections
According to research published in the May issue of The Journal of Nuclear Medicine, molecular imaging can help physicians identify aortic dissection"”an often fatal blood vessel condition"”and help guide treatment. Aortic dissection occurs when a tear in the wall of the aorta causes blood to flow between the layers of the wall of the aorta and force the layers apart.
Aortic dissection is the tenth leading cause of death in Western societies. It is the second most frequent cause of acute chest pain. In 2003, actor John Ritter died suddenly of complications from aortic dissection. Ritter's doctors were not able to identify his true condition until just before his death.
In clinically unclear cases, use of an advanced imaging technique"”positron emission tomography (PET) with the imaging agent fluorodeoxyglucose (FDG) and computed tomography (CT)"”may help determine the age of an aortic dissection, the degree of risk and the need for surgery. Articles by researchers in Japan, Germany and the United Kingdom reported on the results of two studies that used FDG PET/CT to diagnose aortic dissection.
In the Munich study, researchers examined patients with symptoms of aortic dissection and patients with chronic asymptomatic dissection using FDG PET/CT to acquire images of the affected area, just above the heart. These images were studied to determine the difference between the two forms of aortic dissection. The researchers reported that acute dissection of the aortic wall led to elevated metabolic activity in freshly lacerated segments of the aortic wall, while stable chronic aortic dissection showed no increased metabolic activity.
Researchers speculate that increased metabolic activity in cases of acute aortic dissection is due to repair mechanisms of the aortic wall injury, causing cell activation and accumulation, and that low metabolic activity in chronic aortic dissection is due to scar tissue. Further studies are needed to prove these hypotheses.
In another study reported in JNM, researchers in Japan found that greater metabolic activity in acute aortic dissection was significantly associated with increased risk for rupture and progression. The study shows that FDG PET/CT may be used to improve patient management, although more studies are still needed to clarify its role in the clinical setting.
"Usually, it is difficult to predict poor outcome for patients receiving medical treatment for acute aortic dissection," said Toyoaki Murohara, M.D., Ph.D., F.A.H.A., a professor at Nagoya University Graduate School of Medicine in Japan and one of the authors of the study. "This study will give us new information to evaluate the degree of the patients' illness."
"Early diagnosis and treatment are essential for survival of patients with this rare and often fatal disease," said James H.F. Rudd, M.D., Ph.D., M.R.C.P., a researcher and consultant cardiologist at the University of Cambridge, United Kingdom, who authored an invited perspective article in JNM on the role of 18F-FDG PET in aortic dissection. "Although further studies are needed, this research suggests that FDG PET imaging might be used to identify patients who are at a very high risk of complications, allowing them to be fast-tracked to surgery."
Authors of "Imaging of Acute and Chronic Aortic Dissection by 18F-FDG PET/CT" include: Christian Reeps, Jaroslav Pelisek, Manuela Gurdan, Alexander Zimmermann, Stefan Ockert, and Hans-Henning Eckstein, of the Clinic for Vascular Surgery, Klinikum-rechts-der-Isar, Technische Universität Mnchen, Munich, Germany; Ralph A. Bundschuh and Markus Essler, Clinic for Nuclear Medicine, Klinikum-rechts-der-Isar, Technische Universität Mnchen, Munich, Germany; and Martin Dobritz, Institute for Radiology, Klinikum-rechts-der-Isar, Technische Universität Mnchen, Munich, Germany.
Authors of "Uptake of F-18 Fluorodeoxyglucose in Acute Aortic Dissection; a Determinant of Unfavorable Outcome" include: Kimihiko Kato and Tetsuo Fujimaki, Department of Cardiovascular Medicine, Gifu Prefectural Tajimi Hospital, Tajimi, Japan; Akiko Nishio, Hisashi Usami, Department of Radiology, Nagoya University, Graduate School of Medicine, Nagoya, Japan; and Noriyuki Kato, Department of Radiology, Mie University, Graduate School of Medicine, Tsu, Japan; and Toyoaki Murohara, Department of Cardiology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
On the Net: